Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet been described and could take into account how all known determinants improve diagnostics and treatment for the individual patient. Precision public health would lead to the right intervention in each VL endem...
Main Author: | Eduard E. Zijlstra |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.707619/full |
Similar Items
-
Clinical and Laboratory Analysis of Patients with Leishmaniasis: A Retrospective Study from a Tertiary Care Center in New Delhi
by: Nitin GUPTA, et al.
Published: (2017-12-01) -
Asymptomatic Leishmania chagasi Infection in Relatives and Neighbors of Patients with Visceral Leishmaniasis
by: D'Oliveira Júnior Argemiro, et al.
Published: (1997-01-01) -
Potential Biomarkers for Asymptomatic Visceral Leishmaniasis among Iraq-Deployed U.S. Military Personnel
by: Fernanda Fortes de Araujo, et al.
Published: (2023-05-01) -
Optimal control applied to a visceral leishmaniasis model
by: Buddhi Pantha, et al.
Published: (2020-07-01) -
Post kala-azar dermal leishmaniasis masquerading as lepromatous leprosy in a treated case of Hansen′s : A diagnostic dilemma
by: Shikha Arora, et al.
Published: (2012-01-01)